Aidapak Recalls Nebivolol Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Nebivolol HCL 5 mg tablets because they may have been mislabeled as Thyroid or Rasagiline Mesylate.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a moderate severity score. The hazard involves a labeling mixup that could lead to medication errors, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Nebivolol HCL 5 mg tablets (NDC 00456140530) due to a labeling error. The recall was initiated because the tablets may have been mislabeled as Thyroid 30 mg tablets or Rasagiline Mesylate 0.5 mg tablets.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific product codes involved are Pedigree AD73611_7 with an expiration date of 5/30/2014, and Pedigree W002930 with an expiration date of 6/10/2014.
Consumers and healthcare providers should check their inventory for these specific lot codes and expiration dates. If the product is found, it should be returned to the distributor or a healthcare professional should be contacted for guidance on disposal or replacement.
The recalled product
- Product
- NEBIVOLOL HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456140530.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 60
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- NEBIVOLOL HCL
- Tablet
- 5 mg has the following codes: Pedigree: AD73611_7
- EXP: 5/30/2014
- Pedigree: W002930
- EXP: 6/10/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Benazepril HCL Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Benazepril HCL Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Tramadol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls aMILoride Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Propranolol HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22